Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term

Group 1 - Zacks Premium offers various tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1][2] - The Zacks Style Scores provide a rating system for stocks based on value, growth, and momentum, helping investors identify securities with high potential for market outperformance [2][3] Group 2 - The Value Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, and Price/Cash Flow [3] - The Growth Score assesses a company's financial health and future outlook by analyzing projected and historical earnings, sales, and cash flow [4] - The Momentum Score evaluates stocks based on price trends and earnings estimate changes to identify optimal buying opportunities [5] Group 3 - The VGM Score combines the Value, Growth, and Momentum Scores to highlight stocks with the best overall potential [6] - The Zacks Rank is a proprietary model that utilizes earnings estimate revisions to guide investors in building successful portfolios [7][10] Group 4 - Stocks rated 1 (Strong Buy) have historically produced an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal investment potential [10][11] Group 5 - The Cooper Companies Inc operates globally in the specialty medical device sector, with two segments: CooperVision and CooperSurgical [12] - Currently rated 3 (Hold) with a VGM Score of A, Cooper is projected to achieve year-over-year earnings growth of 9.8% for the current fiscal year [12][13] - Recent upward revisions by analysts have increased the Zacks Consensus Estimate for Cooper to $4.05 per share, with an average earnings surprise of 3.2% [13]